Elevance Health: Between Carelon Growth and Margin Pressure – The True Strategy Behind the New Goals
Reading Time: 2 minutes
Confirmed EPS target for 2026 of at least $27.00 (adjusted) despite high special effects. Significant internal synergies from the rapid expansion of the profitable service division Carelon. CEO Gail Boudreaux drives margin protection by consciously forgoing unprofitable member growth. Fundamentals and sectoral growth drivers Elevance Health (ELV) has transformed into a strongly diversified healthcare company. The operational model relies on traditional insurance business and the growth sector Carelon. Through this structure, the company...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
